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Introduction
Esophageal squamous cell carcinoma (ESCC), the predominant histological subtype of esophageal cancer, is the fourth most common malignancy and still represents a great health concern in China. The incidence of ESCC is characterized by the striking geographic variation in incidence throughout the world [1, 2] . Linzhou (formerly Linxian) and Huixian, which geologically belong to Taihang Mountain region in northern China, have the highest incidence of ESCC in the world, with an incidence rate of approximately 150 per 100,000 population [1] . Most of the patients cannot survive more than one year after presenting at healthcare centers and the 5-year survival rate for ESCC remains as low as 10 percent or even less due to complications caused by the aberrant tumor growth in the esophagus, such as dysphagia, cachexia, etc [3, 4] . One of the main reasons for the ominous phenomena is that neoplasms in esophagus are not detected until they have invaded the surrounding tissues or spread throughout the body at advanced stages. The early detection and diagnosis of esophageal malignancy is critical for its therapy and management.
A large number of epidemiological studies suggested that cigarette smoking, alcohol drinking, diets deficiency in vitamins and/or protective antioxidants, thermal injuries caused by hot food, intake of nitrosamine or moldy foodstuff which contain direct or indirect carcinogen have been closely correlated to the prevalence of the esophageal cancer [5] [6] [7] . The etiological factors for ESCC, however, have yet to be clarified. Similar to other types of cancer, ESCC involves a multistage process, featuring a great diversity of genetic and epigenetic alternations. Although various molecular events and morphologic features have been found to closely correlate with malignancies of esophagus, the biomarkers for early detection and diagnosis with high specificity and sensitivity and indices for treatment and management of esophageal malignancy have not been identified.
Proteomics provides an effective approach to study disease pathogenesis by globally examining the different protein expressions due to malignant cell transformation in disease [8, 9] . Proteomic technology has been successfully applied to identify tumor-associated proteins in various cancers originating from different organs including liver [10] , lung [11] , prostate [12] , breast [13] , kidney [14] , tongue [15] , buccal mucosa [16] esophagus [17] , bladder [18] , and cholangiole [19] . In this study, we employed proteomics to analyze ESCC tumor specimens recruited from Linzhou, China, to identify the proteins with significantly different expressions in cancer. The expression patterns of the proteins were then correlated to the different stages of malignancy and differentiation status of the disease. The present findings may shed light on the molecular characterization of esophageal cancer progression and may be informative for identifying biomarkers and therapeutic targets for ESCC.
Materials and Methods

Tissue specimen
Tissues used in this experiment were obtained with the approval of the Committees for Ethical Review of Research involving Human Subjects at Zhengzhou University and the University of Hong Kong. A total of 17 human ESCC specimens were collected immediately after isolation of surgically resected tissues from patients in Linzhou in northern China. The 17 cases include 10 males and 7 females with averaged age of 60.2 ± 7.3 years. Tissue samples were snap-frozen in liquid nitrogen and then preserved in -80 o C deep freezer or on dry ice for transfer before experiments. The histology for all 17 samples was confirmed by two independent histopathologist following fixation, embedding, sectioning and H&E staining. All samples comprised more than 80% of target cells (normal epithelial cells, cells with various grades of disease or cancer cells) without necrosis. These 17 cases were divided into two groups (Table 1) . Group 1 contains 15 pairs of intra-matched tissue specimens, i.e., tumor center tissues and matched normal esophageal epitheliums at least 5 cm distal from primary tumor mass of ESCC. Group 2 has two cases; each contains matched triplet samples including tumor and two pre-tumor lesions at different stages based on Lugol's staining (see below).
Preparation of tissue protein samples
Fresh frozen esophageal tissue samples (100-150 mg) were cut into small pieces, dissolved in lysis buffer at the ratio of 1 mg tissue per 2 µl lysis buffer (Reagent 3, Bio-Rad Laboratories, Hercules, CA, USA) containing protease inhibitor cocktail (Sigma, St. Louis, MO, USA) 8340 and DNase I 1 unit / ml and then homogenized for 5 min on ice with a minihomogenizer. The mixture was centrifuged at 13.2 × 1000 rpm at 4 o C for 15 min to remove tissue and cell debris. The supernatant was taken as extracted proteins and the protein concentration was determined by the Bradford method with BSA as standard. Aliquots of protein samples were kept in -80 o C deep-freezer until further use.
2DE electrophoresis, silver staining and image analysis
Isoelectronic focusing was conducted using Amersham Biosystems IPG-phor. IPG strips with a linear pH range of 3 to 10 were used for protein separation by following a protocol described previously [15, 20] . Proteins of 30 to 50 µg for analytical gels and 100 to 200 µg for preparative gels were utilized for IEF and subsequent second dimensional separation. All samples were run at least in duplicate to guarantee reproducibility. Two good quality gels for each case were included into the subsequent image analysis. Silver staining was performed as previously described [15] . Images of 2D-gels were digitalized with ImageScanner (Amersham Biosciences). Image analyses were conducted with ImageMaster 2D Elite software 4.01 (Amersham Biosciences) [15] . The normalized value for each protein spot volume was used for comparison. Only those spots that have statistical significance in differential expression were selected for further investigation.
In-gel digestion by trypsin
Spots of interest were cut off with a clean scalpel after the preparative gels were washed with Mili-Q water and transferred to a siliconized Eppendorf tube. Stained gel slabs were cut into 1x1 mm pieces and de-stained with 1 ml of 1:1 (v/v) mixture of 30 mM potassium ferricyanide and 100 mM sodium thiosulfate for 10 min and rinsed at least twice with Mili-Q water (1ml for 5 min each) until the yellow color disappeared. The gel slabs were equilibrated with 0.5 ml of 50 mM NH 4 HCO 3 for 10 min and then incubated with 0.5 ml of 1:1 mixture of 50 mM NH 4 HCO 3 and 100% acetonitrile (ACN) for 30 min. Complete dehydration was achieved by incubation of gel slabs with 200 µl of 100% ACN and then gel pieces were dried in a Speed-Vac for 20 min. For the in-gel digestion, the gel particles were rehydrated with a minimal volume of trypsin solution (10 µg/mL in 25 mM NH 4 HCO 3 ) and incubated at 37 o C overnight. The liquid fraction containing digested peptides was spotted onto a sample plate with equal amounts of matrix. Where necessary, the in-gel digests were extracted subsequently with 50% and 80% acetonitrile, and then concentrated and de-salted by Zip tips prior to applying on the sample plate [20] .
MALDI-TOF MS and protein identification by peptide fingerprinting
A Voyage-DE STR MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA, USA) was employed to obtain the peptide mass spectra with the following settings: 
Western blotting
With reference to the verification of candidate proteins after peptide fingerprinting, the proteins of interest were selected for Western blotting to confirm the results of protein database searching. After 1D or 2D electrophoresis, proteins were transferred onto PVDF another antibody, the membranes were stripped with stripping buffer (glycine 3.75 g/L, SDS 2 g/L, pH 2.0) before blocking. Beta-actin, sense primer, 5'-GTGGGGCGCCCCAGGCACCA-3', antisense primer 5'CTCCTTAATGTCACGCACGATTTC 3'.
RNA isolation and RT-PCR
Statistical analysis
Since there are only two cases in group 2, the statistical analysis was performed only for the 15 paired samples in group 1. Comparison was made between 15 normal samples and 15
SCC tumor samples regardless their differentiation states. One-tailed Student's t-test was used for statistically analyzing the data extracted from comparison window of ImageMaster software that displayed the normalized volumes for each protein spot. A value of p<0.05 was considered significant.
Results
Histological diagnosis of ESCC specimens
As shown in Figure 1 & Table 1 , two groups of tissue specimens were classified through detailed histological diagnosis. For the group 1, the 15 matched SCC tumor tissues can be further characterized according to their differentiations into three subgroups, including 1 well-differentiated, 5 moderately-differentiated and 9 poorly-differentiated SCC. The presence of ESCC and intra-matched epithelium were confirmed by subsequent histological examination in which tissue section slides were stained with hematoxylin and eosin ( Fig. 1 ).
For the group 2, Lugol's staining was performed before dissecting tissue specimens harboring precursor lesions of ESCC. Lugol's staining is a well-known procedure to screen out diseased conditions or precursor lesions of tumors originating from squamous epithelium, such as cervix of uterus and esophageal epithelium. Besides the cancer mass, adjacent non-stained and stained areas of esophageal epithelium in Lugol's staining were dissected. The nonstaining area of esophageal mucosae was considered to be precursor lesions for ESCC. As listed in the group 2 in Table 1 , Case 23 comprised tissues of dysplasia (DYS), carcinoma in situ (CIS) and moderately-differentiated SCC; and Case 29 consisted of tissues of basal cell hyperproliferation (BCH), DYS and moderately-differentiated SCC, respectively ( Fig. 1 ).
2DE protein separation and image analysis
Two-dimensional electrophoresis using immobilized pH gradient (linear) ranging from 3 to 10 was performed to separate the proteins extracted from tumor and adjacent normal mucosa or precancerous tissue samples. Figure 2 shows one representative pair of proteome profilings for cancer (A) vs. normal (B) tissue samples. There were around 942 spots unambiguously displayed on the 2D-gels according to the image analysis using software ImageMaster 2D Elite. We found that most of the spots correlated well between 2D maps of cancer and adjacent non-tumor tissues. One-tailed Student's test was utilized to select the protein spots that showed significantly and consistently differences in expression through the intra-paired comparative analysis in ImageMaster. 24 protein spots were revealed to have differential expressions between cancer tissues and adjacent normal esophageal epitheliums with p values less than 0.05 ( Table 2 ). Among these protein spots, 19 were up-regulated and 
Protein identification by peptide mass fingerprinting
Protein spots with statistically consistent and significant differences in protein expression were exercised, subjected to in-gel tryptic digestion, MALDI-TOF mass spectral measurements and peptide mass fingerprinting to obtain protein IDs. Apparently different protein isoforms existed on proteomic profiling due to alternative splicing or post-translation modification. Proteins displaying isoforms are transgelin, GAPDH and alpha enolase.
Correlation of protein expression with histological grades of ESCC
The expression levels of the altered proteins were further correlated to the differentiation status of ESCC in Group 1. As depicted in Figure 4 , we found that the expression changes for protein spots 376 (SCCA1), 586 (Stratifin) and 592 (Prohibitin)
inversely correlate with differentiation grades of ESCC. The protein expression levels decreased with increasing dedifferentiation of ESCC from well-, to moderately-to poorlydifferentiated carcinoma.
Detailed protein expression analysis was also carried out for Group 2 that contains two matched triplets of specimens from the same patients. Figure 5 shows consistent correlation or tendency relationships between lesion grades and protein expressions in the two cases.
Clearly, expression levels of protein spots 534 (TPM4), 592 (Prohibitin), 701 (PRX1) and 706 (MnSOD) linearly increased with progression of disease in the precancerous lesions from DYS to CIS (case 23) and from BCH to DYS (case 29) advancing to SCC. In addition, protein spot 376 (SCCA1) changed its expression level in reverse with the disease severity, consistent with the tendency found in Group 1. A negative linear relationship in terms of SCCA1 expression levels versus the general trend of disease aggravation can be derived.
These protein alterations in expression reflect the dynamic molecular characterization of esophageal carcinogenesis.
Protein ID and expression confirmation by Western blotting
Western blotting was performed to verify three selected proteins, SCCA1, TPM1 and αB-Cryst, that may play functional roles in tumorigenesis. Figure 6 shows the 2D Western blotting results with the corresponding silver staining 2D-gels side by side for the three proteins. Specific and positive immunochemical interactions occurred for the three proteins evaluated. Figure 7A displays the representative gels of 1D Western blotting, confirming the decreased expressions of these three proteins in tumor tissues. Western blotting results shown in Figure 7B exhibit the expression levels of SCCA1, the disease antigen, in the precancerous lesions in the specimens of Group 2. In light with the data generated from the 2D-gel image analysis, SCCA1 expression levels in tissues decreased from DYS → CIS → SCC (case 23) and from BCH → DYS → SCC (case 29), reversely correlated to the aggravation states of the ESCC disease.
RT-PCR
To further verify the unusual expression of SCCA1 in transcription level, RT-PCR experiment was performed to compare the mRNA levels in tumor and non-tumor tissues. Figure 8 shows the RT-PCR results for three representative pairs of the tissue samples. With the mRNA of beta-actin as internal control, the mRNA levels in non-tumor tissues are obviously higher than those in tumor tissues, suggesting that the different expression of SCCA1 takes place at transcription stage.
Discussion
Although numerous studies in genomic field have revealed a magnitude of changes occurring in the multistage pathogenesis of ESCC, including mutations of a variety of tumor suppressor genes and oncogenes, changes in transcription, proliferation-associated factors and metastasis-related factors, these changes may not necessarily warrant subsequent corresponding alternations at the protein levels or functions [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Proteomics, which aims at characterizing the entire protein complement expressed in cells or tissues, provides complementary information and direct evidences to unravel tumor-specific molecular events during multistage carcinogenesis. In the present study, we used 2DE based proteomics to examine the protein profiles of cancer tissues and the adjacent non-tumor tissues freshly collected from Linzhou, the highest ESCC incident area in northern China, to identify proteins related to esophageal malignancy. A total of 20 proteins were uncovered with differential expressions in esophageal carcinogenesis, among which 15 were up-regulated and 5 were down-regulated.
The first intriguing identification is SCC antigen, SCCA1, which was found underexpressed in ESCC. Initially isolated from human cervical SCC tissue [31] , SCCA belongs to a serine protease inhibitor family (serpins). Serpins were found to be involved in a variety of biological functions, including fibrinolysis, coagulation, inflammation, tumor cell invasion, cellular differentiation and apoptosis [32] . Biological studies have revealed that SCCA1 may function in cancer cells for tumor growth, and in normal squamous epithelium for differentiation by inhibiting apoptosis [33] . The SCC antigen was found highly upregulated in various SCC cancers including those in the uterine cervix, lung, head and neck, skin [33, 34] and recently in buccal mucosa [16] ; this protein was therefore regarded as a SCC tumor marker. However, we observed that SCCA1 expression in ESCC cancer tissues was suppressed by 2.5 folds compared to adjacent normal tissues (Table 1 ). This unusual observation was further validated by Western blotting data, showing that the underexpression of SCCA1 not only takes place in tumor tissues in general ( Fig. 7A ) but also proceeds correlatively with malignant potential (Fig. 7B) . A similar trend of SCCA1 downregulation in ESCC tumor was found in RT-PCR experiment (Fig. 8 ), suggesting its firm occurrence in transcription level. This finding, although contradictory to the results from previous studies with other SCC cancers, implicates that the SCCA1 may have a unique function in esophagus SCC tumorigenesis. In addition, the decreased expression of SCCA1
can be linearly correlated to the differentiation progression of the disease in Group 1 (Fig. 4 ).
This finding is consistent well with early observations that patients with well-differentiated esophageal tumors tended to have higher SCCA1 levels compared to those with poorly differentiated tumors [35, 36] . Therefore, it is likely that SCCA1 is an indicator for the histological differentiation of the ESCC [37] .
A group of cytoskeleton microfilaments-associated proteins, including cytoplasmic actin, gamma-actin, transgelin, TPM1, TPM4, tubulin alpha-1 chain and tubulin beta-5 chain, were found to express differentially between cancer and normal tissues. Actin network is essential for cellular functions such as motility, division and cell surface receptor movement, anchorage dependence, and contact inhibition. During malignant transformation, expression alternations in actin microfilament network and other actin-associated proteins always accompany morphological changes [38] [39] [40] [41] . Previous studies have demonstrated that expression changes in cytoskeleton-associated proteins, including actin, TPM, gelsolin, caldesmon, myosin light chain, have been implicated in transformed phenotypes [41] .
Tropomyosin (TPM) is a major structural component of cytoskeletal microfilament and multiple TPM isoforms have been reported in cultured non-muscle cells. Interestingly, opposite expression regulations for different TPM isoforms have been often found in tumors, implying that these isoforms may have different functions in cell transformation. For example, under-expressions of high MW TPM have been reported in various cancers such as oral tongue squamous cell carcinoma [15] , breast [39, 42] and colon [42] cancers. Up-regulation of lower MW TPM isoforms has been implicated to be associated with metastatic potential of primary breast carcinoma [43] , melanoma [44] and Lewis lung carcinoma [45] . transgelin expression was at higher level in normal ductal epithelial cells than in DCIS cells [13] . Transgelin gene expression at mRNA level was greatly reduced or lost in transformed and tumor cell lines [42] . However, a recent protein profile study discovered that transgelin was over-expressed in stomach cancer tissue [46] . Our current observation testified that transgelin expression was dramatically increased in ESCC, with a phenomenon that one distinct transgelin isoform (spot 808) presents exclusively in the cancer tissues ( Fig. 3) .
Given the fact that esophagus and stomach are closely related in digestive tract, ESCC and stomach cancer may be subjected to a similar stimulation in term of cell malignant transformation related to transgelin expression. The underlying nature of transgelin functions in the tumorigenesis of esophagus and stomach warrants further investigation.
Accumulating evidence has indicated that intracellular redox state plays important roles in cellular signal transduction and gene expression [47] . Reactive oxygen species (ROS), which are produced in cells during physiological processes in response to external stimuli, can affect intracellular redox state. At low levels, ROS modulate gene expression through modulating cellular redox state; at high levels, ROS are highly deleterious and potentially damage DNA, proteins, carbohydrates and lipids. It has been suggested that ROS play roles in all stages of carcinogenesis, including initiation, promotion, and progression [48] . In order to protect themselves from oxidative radical stress, cells have developed defense systems that comprise proteins superoxide dismutases (SOD), catatalse, glutathione peroxidases, and preoxiredoxins (PRX). The up-regulations of MnSOD and PRX1 in ESCC and their linear correlations with progression of disease from pre-malignant to invasive cancer (Fig. 5 ) reflect the cell defense effort in maintaining intracellular homeostasis. Similar observations have been found in other cancers including the over-expression of PRX in malignant mesothelioma [49] , lung cancer [50] and oral cancer [51] , and over-expression of MnSOD in human prostate cancer cell lines [52] and in buccal SCC [16] . Interestingly, a minor down-regulation of PRX2 isoform was detected in ESCC, suggesting that different PRX isoforms may have slightly different functions unique to the esophageal neoplasms.
Alpha B crystalline is a member of small heat shock proteins (HSPs) which are ubiquitous chaperon molecules related to stresses. They can protect cells from damage through binding to partially denatured proteins, dissociating protein aggregates, modulating the correct folding, and cooperating in transporting newly synthesized polypeptides to the target organelles [53] . αB-Cryst was able to inhibit both the mitochondrial and death receptor apoptotic pathways through abolishing the autoproteolytic maturation of partially processed caspase-3 intermediate [54] . Intriguingly, while other HSPs were usually up-regulated in tumors, αB-Cryst was often down-regulated in various cancers [15, [55] [56] [57] [58] [59] . Our present data reinforced this observation with αB-Cryst being markedly suppressed in ESCC tissues. These results again revealed that αB-Cryst plays a role distinctive from other HSPs in carcinogenesis and implicated that under-expression of αB-Cryst may be a general marker for various tumors.
Stratifin, also known as 14-3-3σ or HME-1, was recently reported to be a candidate tumor suppressor gene that is transactivated by p53 in response to DNA damage and negatively regulates both G1/S and G2/M cell cycle progression [60, 61] . Over-expression of stratifin increased stabilization of p53 through blocking Mdm2-mediated p53 ubiquitination and enhanced oligomerization of p53, leading to an increase in p53 transcriptional activity [62] . Several studies have reported the potent role of stratifin in tumorigenesis of various organs, including prostate, urinary bladder, and breast [18, 63, 64] . In line with other published data, a small but significant under-expression of stratifin was found in cancer tissues in the present study, implicating its probable contribution to pathogenesis of esophageal neoplasms. Additionally, the stratifin expression was inversely correlated with differentiation grade of ESCC ( Fig. 4) , indicating that malignant cells arising from esophageal epithelium may lose stratifin in progressive dedifferentiation.
Another potential tumor suppressor protein, prohibitin was revealed to be differentially expressed between cancer tissue and adjacent normal epithelium. Interestingly, prohibitin expression positively correlated with the progression of precancerous lesions ( Fig. 5 ) but inversely correlated with the differentiation grades of squamous cell carcinoma of esophagus (Fig 4) . This expression manner indicates that prohibitin may play different roles at different stages of esophageal tumorigenesis by acting on cell proliferation. One study using RNA interference to knock down prohibitin and using transient transfection to over-express the protein demonstrated that cells with reduced prohibitin displayed a slight increase in the percentage of cell population in cell cycle, while cells with increased prohibitin showed a clear reduction in the percentage entering cell cycle following dihydrotestosterone stimulation [65] .
In summary, we used 2D-gel based proteomics to compare the protein profiles between 
